Global Allergy Immunotherapy Market: Trends and Opportunities (2015-2019)
Scope of the Report
The report titled “Global Allergy Immunotherapy Market: Trends & Opportunities (2015-2019)” provides an in-depth analysis of the global allergy immunotherapy market with detailed analysis of market sizing and growth, market share and economic impact of the industry. Global allergy immunotherapy market penetration rate is also provided in the report. The report also provides market size of allergic rhino conjunctivitis (AR) and HDM allergy disease. The report provides detailed market share analysis of the global allergy immunotherapy market by types, regions and players. The market share of allergy immunotherapy market in the respiratory market and prescription allergy market is also explained in detailed.
The report provides detail regional analysis of the allergy immunotherapy market in the United States and Europe. In regional analysis market by value, key players are provided with market for pipeline products.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy industry has also been forecasted for the period 2014-2019, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition is global allergy immunotherapy market is stiff and dominated by the big players like ALK-Abello. Further, key players of the allergy immunotherapy industry like ALK-Abello, Stallergenes; and Allergy Therapeutics are also profiled with their financial information and respective business strategies.
Country Coverage
Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Allergy shots decrease sensitivity to allergens that’s why it is known as “desensitization or hypo-sensitization” and often lead to lasting relief of allergy symptoms even after treatment is stopped. This makes it a cost-effective, beneficial treatment approach for many people. Allergen immunotherapy is a preventive treatment for allergic reactions to substances such as grass pollens, house dust mites and bee venom. Whole allergen immunotherapy is the only treatment that targets the actual cause of the allergy and attempts to re-educate the immune system to tolerate the allergen.
In the 2013 ‘World Allergy Organization White Book’, the WHO estimated that there were 400 million people in the world suffering from allergic rhinitis and 300 million from asthma, which shows the scale of the problem. The most common allergens found in the US and Europe.
Patients presenting with allergies are questioned and the tested in an attempt to ascertain exactly what they are allergic to. Once this has been identified, a treatment regime can be put in place. However, the approaches in the US and Europe are quite different, largely because of differences in product availability. The type of product used falls into three categories: SCIT, SLITD and SLITT.
The report titled “Global Allergy Immunotherapy Market: Trends & Opportunities (2015-2019)” provides an in-depth analysis of the global allergy immunotherapy market with detailed analysis of market sizing and growth, market share and economic impact of the industry. Global allergy immunotherapy market penetration rate is also provided in the report. The report also provides market size of allergic rhino conjunctivitis (AR) and HDM allergy disease. The report provides detailed market share analysis of the global allergy immunotherapy market by types, regions and players. The market share of allergy immunotherapy market in the respiratory market and prescription allergy market is also explained in detailed.
The report provides detail regional analysis of the allergy immunotherapy market in the United States and Europe. In regional analysis market by value, key players are provided with market for pipeline products.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy industry has also been forecasted for the period 2014-2019, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition is global allergy immunotherapy market is stiff and dominated by the big players like ALK-Abello. Further, key players of the allergy immunotherapy industry like ALK-Abello, Stallergenes; and Allergy Therapeutics are also profiled with their financial information and respective business strategies.
Country Coverage
- United States
- Europe
- ALK-Abello
- Stallergenes
- Allergy Therapeutics
Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Allergy shots decrease sensitivity to allergens that’s why it is known as “desensitization or hypo-sensitization” and often lead to lasting relief of allergy symptoms even after treatment is stopped. This makes it a cost-effective, beneficial treatment approach for many people. Allergen immunotherapy is a preventive treatment for allergic reactions to substances such as grass pollens, house dust mites and bee venom. Whole allergen immunotherapy is the only treatment that targets the actual cause of the allergy and attempts to re-educate the immune system to tolerate the allergen.
In the 2013 ‘World Allergy Organization White Book’, the WHO estimated that there were 400 million people in the world suffering from allergic rhinitis and 300 million from asthma, which shows the scale of the problem. The most common allergens found in the US and Europe.
Patients presenting with allergies are questioned and the tested in an attempt to ascertain exactly what they are allergic to. Once this has been identified, a treatment regime can be put in place. However, the approaches in the US and Europe are quite different, largely because of differences in product availability. The type of product used falls into three categories: SCIT, SLITD and SLITT.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 History
2.2 Allergy
2.3 Allergic Response
Type I reactions – IgE-Mediated Allergies
2.4 Types of Allergy
2.5 Symptoms
2.6 Anaphylaxis
2.7 Prevention
2.8 Treatment
2.8.1 Medicines
Anti-Histamines
Decongestants
Steroids
2.8.2 Immunotherapy
2.9 Allergen Immunotherapy
2.9.1 Allergy Vaccines
2.9.2 Allergoids
2.9.3 Role of Adjuvants
3-O-DESACYL-4’-MONOPHOSPHORYL LIPID A (MPL)
L-tyrosine
2.9.4 Types
Subcutaneous
Sublingual
Oral
2.9.5 Mechanism of Action
2.10 Allergy Diagnostics
2.10.1 Skin Prick Test
2.10.2 In-Vitro Tests for Allergen-Specific IgE
3. GLOBAL ALLERGY THERAPEUTICS MARKET: AN ANALYSIS
3.1 Global Allergy Immunotherapy Market: Sizing & Growth
3.1.1 Global Allergy Immunotherapy Market by Value
3.1.2 Allergy Immunotherapy Patients by Regions
3.1.3 Allergy Immunotherapy Market Penetration Rate
3.1.4 Allergic Rhino Conjunctivitis (AR) Patients by Regions
3.1.5 HDM Allergy Disease Patients by Regions
3.2 Global Allergen Immunotherapy Market Share Analysis
3.2.1 Global Allergen Immunotherapy Market by Types
3.2.2 Global Allergen Immunotherapy Market Share by Regions
3.2.3 Global Allergy Immunotherapy Market Share in Respiratory Market
3.2.4 Global Allergy Immunotherapy Market Share in Prescription Allergy Market
3.2.5 Global Allergy Immunotherapy Market Share by Players
4. ALLERGY IMMUNOTHERAPY MARKET: REGIONAL ANALYSIS
4.1 The US Allergy Immunotherapy Market: Sizing and Growth
4.1.1 The US Allergy Immunotherapy Market by Type
4.1.2 The US Allergy Immunotherapy Market by Key Players
4.1.3 The US Allergy Immunotherapy Market by Pipeline Products
4.2 Europe Allergy Immunotherapy Market: Sizing and Growth
4.2.1 Europe Allergy Immunotherapy Market by Type
4.2.2 Europe Allergy Immunotherapy Market by Key Players
4.2.3 Europe Allergy Immunotherapy Market by Countries
4.2.4 Europe Allergy Immunotherapy Market by Pipeline Products
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Spending on Medicines
5.1.2 Rise in GDP
5.1.3 Increasing Environmental Pollution
5.1.4 Increasing Prevalence of Allergic Disease
5.2 Challenges
5.2.1 Management of Allergy
5.2.2 Awareness of Allergic Problems
5.3 Market Trends
5.3.1 Increasing Prevalence of Food and Skin Allergies
5.3.2 Price Trends
6. COMPETITIVE LANDSCAPE
7. COMPANY PROFILES
7.1 Allergy Therapeutics
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Stallergenes
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 ALK-Abello
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
2. INTRODUCTION
2.1 History
2.2 Allergy
2.3 Allergic Response
Type I reactions – IgE-Mediated Allergies
2.4 Types of Allergy
2.5 Symptoms
2.6 Anaphylaxis
2.7 Prevention
2.8 Treatment
2.8.1 Medicines
Anti-Histamines
Decongestants
Steroids
2.8.2 Immunotherapy
2.9 Allergen Immunotherapy
2.9.1 Allergy Vaccines
2.9.2 Allergoids
2.9.3 Role of Adjuvants
3-O-DESACYL-4’-MONOPHOSPHORYL LIPID A (MPL)
L-tyrosine
2.9.4 Types
Subcutaneous
Sublingual
Oral
2.9.5 Mechanism of Action
2.10 Allergy Diagnostics
2.10.1 Skin Prick Test
2.10.2 In-Vitro Tests for Allergen-Specific IgE
3. GLOBAL ALLERGY THERAPEUTICS MARKET: AN ANALYSIS
3.1 Global Allergy Immunotherapy Market: Sizing & Growth
3.1.1 Global Allergy Immunotherapy Market by Value
3.1.2 Allergy Immunotherapy Patients by Regions
3.1.3 Allergy Immunotherapy Market Penetration Rate
3.1.4 Allergic Rhino Conjunctivitis (AR) Patients by Regions
3.1.5 HDM Allergy Disease Patients by Regions
3.2 Global Allergen Immunotherapy Market Share Analysis
3.2.1 Global Allergen Immunotherapy Market by Types
3.2.2 Global Allergen Immunotherapy Market Share by Regions
3.2.3 Global Allergy Immunotherapy Market Share in Respiratory Market
3.2.4 Global Allergy Immunotherapy Market Share in Prescription Allergy Market
3.2.5 Global Allergy Immunotherapy Market Share by Players
4. ALLERGY IMMUNOTHERAPY MARKET: REGIONAL ANALYSIS
4.1 The US Allergy Immunotherapy Market: Sizing and Growth
4.1.1 The US Allergy Immunotherapy Market by Type
4.1.2 The US Allergy Immunotherapy Market by Key Players
4.1.3 The US Allergy Immunotherapy Market by Pipeline Products
4.2 Europe Allergy Immunotherapy Market: Sizing and Growth
4.2.1 Europe Allergy Immunotherapy Market by Type
4.2.2 Europe Allergy Immunotherapy Market by Key Players
4.2.3 Europe Allergy Immunotherapy Market by Countries
4.2.4 Europe Allergy Immunotherapy Market by Pipeline Products
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Spending on Medicines
5.1.2 Rise in GDP
5.1.3 Increasing Environmental Pollution
5.1.4 Increasing Prevalence of Allergic Disease
5.2 Challenges
5.2.1 Management of Allergy
5.2.2 Awareness of Allergic Problems
5.3 Market Trends
5.3.1 Increasing Prevalence of Food and Skin Allergies
5.3.2 Price Trends
6. COMPETITIVE LANDSCAPE
7. COMPANY PROFILES
7.1 Allergy Therapeutics
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Stallergenes
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 ALK-Abello
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
LIST OF FIGURES AND TABLES
Figure 1: Incidence of Allergies in the 20th Century-% of Population
Figure 2: Progression of Allergic Response
Figure 3: Inflammatory Mechanism and Effect of AIT
Figure 4: Interaction between Allergoid and Adjuvant
Figure 5: Global Allergy Immunotherapy Market by Value; 2011-2015E (US$ Million)
Figure 6: Global Allergy Immunotherapy Market by Value; 2016-2019E (US$ Million)
Figure 7: Allergy Immunotherapy Patients by Regions; 2014 (Million)
Figure 8: Allergy Immunotherapy Market Penetration Rate by Regions; 2014 (%)
Figure 9: Allergic Rhino Conjunctivitis (AR) Patients by Regions; 2014
Figure 10: HDM Allergy Disease Patients by Regions; 2014
Figure 11: Global Allergen Immunotherapy Market by Types; 2014
Figure 12: Global Allergen Immunotherapy Market by Region; 2014
Figure 13: Global Allergen Immunotherapy Market Share in Respiratory Market; 2014
Figure 14: Global Allergen Immunotherapy Market by Region; 2014
Figure 15: Global Allergen Immunotherapy Market by Players; 2014
Figure 16: The US Allergy Immunotherapy Market by Type; 2014
Figure 17: The US Allergy Immunotherapy Market by Key Players; 2014
Figure 18: Europe Allergy Immunotherapy Market by Type; 2014
Figure 19: Europe Allergy Immunotherapy Market by Key Players; 2014
Figure 20: Europe Allergy Immunotherapy Market by Countries; 2014
Figure 21: Spending on Medicines; 2005-2015E (US$ Billion)
Figure 22: Rise in GDP; 2005-2014 (US$ Trillion)
Figure 23: Comparison of Air Pollution Level (PM2.5 Concentration) by Country; 2013 (in µg/m3)
Figure 24: Percentage of Children Aged 0-17 Years with Allergic Condition in the US; 1997-2015E
Figure 25: AGY Therapeutics Net Sales; 2013-2015E (US$ Million)
Figure 26: AGY Therapeutics Product Sales Mix; 2014
Figure 27: Stallergenes Product Portfolio
Figure 28: Stallergenes Net Sales; 2012-2014 (US$ Million)
Figure 29: ALK-Abello Net Sales; 2010-2014 (US$ Million)
Figure 30: ALK-Abello Product Sales Mix; 2014
Table 1: Common Types of Allergens
Table 2: Allergy Statistics
Table 3: The US Allergy Immunotherapy Market by Pipeline Products; 2014
Table 4: Europe Allergy Immunotherapy Market by Pipeline Products; 2014
Table 5: Comparative Analysis of the Key Players; 2014
Table 6: Revenue Analysis of the Key Players; 2011-2015E
Table 7: Development Stage Product Pipeline; 2014
Figure 1: Incidence of Allergies in the 20th Century-% of Population
Figure 2: Progression of Allergic Response
Figure 3: Inflammatory Mechanism and Effect of AIT
Figure 4: Interaction between Allergoid and Adjuvant
Figure 5: Global Allergy Immunotherapy Market by Value; 2011-2015E (US$ Million)
Figure 6: Global Allergy Immunotherapy Market by Value; 2016-2019E (US$ Million)
Figure 7: Allergy Immunotherapy Patients by Regions; 2014 (Million)
Figure 8: Allergy Immunotherapy Market Penetration Rate by Regions; 2014 (%)
Figure 9: Allergic Rhino Conjunctivitis (AR) Patients by Regions; 2014
Figure 10: HDM Allergy Disease Patients by Regions; 2014
Figure 11: Global Allergen Immunotherapy Market by Types; 2014
Figure 12: Global Allergen Immunotherapy Market by Region; 2014
Figure 13: Global Allergen Immunotherapy Market Share in Respiratory Market; 2014
Figure 14: Global Allergen Immunotherapy Market by Region; 2014
Figure 15: Global Allergen Immunotherapy Market by Players; 2014
Figure 16: The US Allergy Immunotherapy Market by Type; 2014
Figure 17: The US Allergy Immunotherapy Market by Key Players; 2014
Figure 18: Europe Allergy Immunotherapy Market by Type; 2014
Figure 19: Europe Allergy Immunotherapy Market by Key Players; 2014
Figure 20: Europe Allergy Immunotherapy Market by Countries; 2014
Figure 21: Spending on Medicines; 2005-2015E (US$ Billion)
Figure 22: Rise in GDP; 2005-2014 (US$ Trillion)
Figure 23: Comparison of Air Pollution Level (PM2.5 Concentration) by Country; 2013 (in µg/m3)
Figure 24: Percentage of Children Aged 0-17 Years with Allergic Condition in the US; 1997-2015E
Figure 25: AGY Therapeutics Net Sales; 2013-2015E (US$ Million)
Figure 26: AGY Therapeutics Product Sales Mix; 2014
Figure 27: Stallergenes Product Portfolio
Figure 28: Stallergenes Net Sales; 2012-2014 (US$ Million)
Figure 29: ALK-Abello Net Sales; 2010-2014 (US$ Million)
Figure 30: ALK-Abello Product Sales Mix; 2014
Table 1: Common Types of Allergens
Table 2: Allergy Statistics
Table 3: The US Allergy Immunotherapy Market by Pipeline Products; 2014
Table 4: Europe Allergy Immunotherapy Market by Pipeline Products; 2014
Table 5: Comparative Analysis of the Key Players; 2014
Table 6: Revenue Analysis of the Key Players; 2011-2015E
Table 7: Development Stage Product Pipeline; 2014
